Skip to content
Catalyst

knowcompoundsLycopenefindings

Every finding on lycopene

15 findings, by evidence strength

Direction
Strength, at least

15 shown

  1. Prostate cancer incidencecontestedMoved: lowersEffect, as reportedHR0.46[0.23 to 0.95]Evidence: Moderatereplicated ×1Paper: PMID 412146502025
    Who
    Men aged 55-80 years at high cardiovascular risk from the PREDIMED trial; highest versus lowest quartile of cumulative dietary lycopene intake, fully adjusted model
    Dose studied
    not reported

    Participants in the highest quartile of lycopene intake displayed a significant 54% lower risk of prostate cancer compared to the lowest quartile (HR: 0.46; 95% CI: 0.23–0.95, p-trend = 0.035) in the fully adjusted model (Table 2, Fig. 1).”

    Quoted verbatim from Lycopene intake and prostate cancer risk in men at high cardiovascular risk: a prospective cohort study.cohortPermalink
  2. Incidence of strokeMoved: lowersEffect, as reportedRR0.807[0.68 to 0.957]Evidence: ModeratePaper: PMID 248489402014
    Who
    Adults free of stroke at baseline in seven prospective cohort studies (four dietary lycopene, three circulating lycopene), highest versus lowest lycopene category, confounder-adjusted
    Dose studied
    not reported

    Specifically, lycopene decreased stroke risk by 19.3% (RR = 0.807, 95% CI = 0.680–0.957), and no heterogeneity was observed (p = 0.234, I2 = 25.5%).”

    Quoted verbatim from Dietary and circulating lycopene and stroke risk: a meta-analysis of prospective studies.meta-analysisPermalink
  3. Flow-mediated dilationMoved: raisesEffect, as reportedMD1.36[0.2 to 2.51]Evidence: ModeratePaper: PMID 425881282026Industry funded
    Who
    Healthy adults; meta-analysis of four continuous-intake (at least 7 days) trials of lycopene-containing products versus control without or with very low lycopene
    Dose studied
    not reported

    The results showed a significant increase in FMD in the lycopene group compared with the control group (MD = 1.36, 95% CI: 0.20, 2.51, p = 0.02), with low heterogeneity (I2 = 24%).”

    Quoted verbatim from Effect of Intake of Lycopene-Containing Products on Vascular Endothelial Function in Healthy Adults: A Systematic Review with Meta-Analysis.meta-analysisPermalink
  4. Interleukin-6 concentrationMoved: lowersEvidence: ModeratePaper: PMID 427390332026Industry funded
    Who
    Collegiate badminton players after high-intensity training; hyperbaric oxygen plus lycopene capsules versus hyperbaric oxygen plus placebo capsules (hyperbaric oxygen given to both arms); post-intervention timepoint
    Dose studied
    15 mg lycopene daily (three 5 mg softgels with dinner)

    Furthermore, at post, compared with the HBO group, the IL-6 levels was significantly reduced in the HBO+LYC group (p < 0.05) (Table S2).”

    Quoted verbatim from Effects of Hyperbaric Oxygen Combined with Lycopene on Oxidative Stress and Inflammation in Collegiate Badminton Players After High-Intensity Training.RCT · 4 weeksPermalink
  5. Serum creatine kinase activityMoved: lowersEvidence: ModeratePaper: PMID 427390332026Industry funded
    Who
    Collegiate badminton players after high-intensity training; hyperbaric oxygen plus lycopene capsules versus hyperbaric oxygen plus placebo capsules (hyperbaric oxygen given to both arms); post-intervention timepoint
    Dose studied
    15 mg lycopene daily (three 5 mg softgels with dinner)

    Furthermore, at post, compared with the HBO group, the CK levels were significantly reduced in the HBO+LYC group (p < 0.05) (Table S3).”

    Quoted verbatim from Effects of Hyperbaric Oxygen Combined with Lycopene on Oxidative Stress and Inflammation in Collegiate Badminton Players After High-Intensity Training.RCT · 4 weeksPermalink
  6. Birth weightMoved: raisesEvidence: ModeratePaper: PMID 294382872018
    Who
    180 mother-infant pairs at delivery in a Midwestern US academic medical center; maternal serum trans-lycopene by HPLC, not a dosed exposure
    Dose studied
    not reported

    Maternal trans-lycopene concentrations were positively associated with birth weight (p = 0.04), birth weight percentile ranking (p = 0.01), head circumference (p = 0.007), and birth length percentile ranking (p = 0.02).”

    Quoted verbatim from Serum Lycopene Concentrations and Associations with Clinical Outcomes in a Cohort of Maternal-Infant Dyads.cohortPermalink
  7. Gastric cancer incidenceMoved: lowersEffect, as reportedOR0.15[0.06 to 0.35]Evidence: Limitedreplicated ×1Paper: PMID 353453572022
    Who
    Vietnamese men, hospital-based case-control: 80 incident stomach cancer cases and 146 controls; dietary trans-lycopene intake by food frequency questionnaire, top vs bottom tertile
    Dose studied
    not reported

    Both Trans-Lycopene and β-Cryptoxanthin intake and stomach cancer showed a significantly inverse association, tertile-3 versus tertile-1, (OR = 0.15, 95%CI: 0.06–0.35, p trend = 0.00) and (OR = 0.34, 95%CI: 0.14–0.79, p trend = 0.02, respectively).”

    Quoted verbatim from Trans-Lycopene and β-Cryptoxanthin Intake and Stomach Cancer in Vietnamese Men: A Pilot Case-Control Study.case-controlPermalink
  8. Gastric cancer incidenceMoved: lowersEffect, as reportedOR0.88[0.81 to 0.95]Evidence: Limitedreplicated ×1Paper: PMID 419781932026
    Who
    Hospital-based case-control study in Hanoi, Vietnam: 1182 incident gastric cancer cases and 2995 controls; dietary lycopene by food frequency questionnaire; whole-sample estimate per SD increment
    Dose studied
    not reported

    Overall, there was a dose–response inverse association between lycopene intake and gastric cancer risk (ORper-SD increment = 0.88, 95% CI: 0.81–0.95; Ptrend = 0.002).”

    Quoted verbatim from Dietary Lycopene Intake and Gastric Cancer Risk: Findings from a Case-Control Study.case-controlPermalink
  9. Non-vertebral fracture incidenceMoved: lowersEvidence: Very limitedPaper: PMID 191381292009
    Who
    Framingham Osteoporosis Study men and women, mean age 75, dietary lycopene by food frequency questionnaire in tertiles, followed to 2003 for nonvertebral fracture; adjusted for sex, age, BMI, height, energy, calcium, vitamin D, activity, alcohol, smoking, multivitamin and estrogen use
    Dose studied
    not reported

    Subjects with higher lycopene intake had lower risk of hip fracture (p =0.01) and nonvertebral fracture (p = 0.02).”

    Quoted verbatim from Protective effect of total carotenoid and lycopene intake on the risk of hip fracture: a 17-year follow-up from the Framingham Osteoporosis Study.cohortPermalink
  10. Prostate cancer incidencecontestedMoved: lowersEvidence: Very limitedreplicated ×1Paper: PMID 244632482014
    Who
    49898 male health professionals followed 1986 to 2010; dietary lycopene from food frequency questionnaires
    Dose studied
    not reported

    Higher lycopene intake was inversely associated with total prostate cancer and more strongly with lethal prostate cancer (top vs bottom quintile: HR = 0.72; 95% CI = 0.56 to 0.94; P(trend) = .04).”

    Quoted verbatim from Dietary lycopene, angiogenesis, and prostate cancer: a prospective study in the prostate-specific antigen era.cohortPermalink
  11. Hip fracture incidenceMoved: lowersEvidence: Very limitedPaper: PMID 191381292009
    Who
    Framingham Osteoporosis Study men and women, mean age 75, dietary lycopene by food frequency questionnaire in tertiles, followed to 2005; adjusted for sex, age, BMI, height, energy, calcium, vitamin D, activity, alcohol, smoking, multivitamin and estrogen use
    Dose studied
    not reported

    Subjects with higher lycopene intake had lower risk of hip fracture (p =0.01) and nonvertebral fracture (p = 0.02).”

    Quoted verbatim from Protective effect of total carotenoid and lycopene intake on the risk of hip fracture: a 17-year follow-up from the Framingham Osteoporosis Study.cohortPermalink
  12. Glycated haemoglobin (HbA1c)Moved: lowersEvidence: Very limitedPaper: PMID 341803362021
    Who
    Patients with type 2 diabetes mellitus within a case-control study; dietary lycopene by food frequency questionnaire; association with intake level
    Dose studied
    not reported

    Contrarily, HbA1c and FPG levels decreased significantly with the higher lycopene intake.”

    Quoted verbatim from The role of lycopene for the amelioration of glycaemic status and peripheral antioxidant capacity among the Type II diabetes mellitus patients: a case-control study.case-controlPermalink
  13. Fasting blood glucoseMoved: lowersEvidence: Very limitedPaper: PMID 341803362021
    Who
    Patients with type 2 diabetes mellitus within a case-control study; dietary lycopene by food frequency questionnaire; association with intake level
    Dose studied
    not reported

    Contrarily, HbA1c and FPG levels decreased significantly with the higher lycopene intake.”

    Quoted verbatim from The role of lycopene for the amelioration of glycaemic status and peripheral antioxidant capacity among the Type II diabetes mellitus patients: a case-control study.case-controlPermalink
  14. Serum prostate-specific antigenMoved: no difference foundEffect, as reportedMD−0.34[−2.01 to 1.32]Evidence: Very limitedPaper: PMID 220718402011
    Who
    Men in a meta-analysis of randomised trials of lycopene for prostate cancer prevention; three RCTs with 154 participants overall, differing in design, participants and lycopene allocation
    Dose studied
    not reported

    Meta-analysis indicated no statistical difference in PSA levels between men randomised to receive lycopene and the comparison group (MD (mean difference) -0.34, 95% CI (confidence interval) -2.01, 1.32).”

    Quoted verbatim from Lycopene for the prevention of prostate cancer.meta-analysisPermalink
  15. Prostate cancer incidencecontestedMoved: no difference foundEvidence: InsufficientPaper: PMID 213355072011
    Who
    Men in the Prostate Cancer Prevention Trial (nested case-control, biopsy-determined prostate cancer, 1,683 cases and 1,751 controls); serum lycopene as exposure, all Gleason grades
    Dose studied
    not reported

    There were no associations of lycopene with prostate cancer risk.”

    Quoted verbatim from Serum lycopene concentration and prostate cancer risk: results from the Prostate Cancer Prevention Trial.case-controlPermalink

No dose is advised.